NewCardio Study of my3KG Performance in Diagnosis of AMI Selected for Presentation at the Society for Academic Emergency Medicine Annual Meeting
Study Done in Collaboration with Emergency Medicine and Cardiology Experts from University of Minnesota and Kansas University Medical Center
SANTA CLARA, Calif., March 10, 2011 /PRNewswire/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiovascular diagnostic solutions developer, announced today that the results of a my3KG performance study will be made at the Society for Academic Emergency Medicine (SAEM) Annual Meeting, to be held in Boston, MA, June 1-5, 2011.
The study, entitled "A New Computer Algorithm Performs Better than Cardiologists in the Diagnosis of Acute Myocardial Infarction," will be presented at the SAEM meeting by Dr. Stephen W. Smith, Associate Professor of Emergency Medicine, University of Minnesota and Hennepin County Medical Center (HCMC), Minneapolis MN. Co-investigators in this study included Drs. Victor Romo and James Miner, Emergency Medicine, HCMC; and Drs. Dajuanna Lakireddy, Subba Vanga, and Sudha Bommana, Kansas University Cardiovascular Research Institute, Kansas City, KS.
The SAEM presentation will address a key diagnostic problem in Emergency Department (ED) patients – the low diagnostic sensitivity of the standard 12-lead ECG in early diagnosis of acute myocardial infarction (MI).
Dr. Smith commented, "The standard 12-lead ECG plays a critical role in MI diagnosis, but its low sensitivity – even with expert physician interpretation - leads to diagnostic delays and errors. To the extent that my3KG can improve diagnostic sensitivity for acute MI, it is an important result that may lead to faster and more accurate MI diagnosis in the ED."
Dr. Ihor Gussak, NewCardio's Chief Medical Officer, commented, "We were delighted that Dr. Smith collaborated with us in this study. He is an internationally known and well-respected emergency medicine specialist with particular expertise in clinical electrocardiology and diagnosis of acute coronary syndromes. He is highly influential among ED physicians, who represent a key potential constituency for my3KG. We look forward to the SAEM presentation, and to completing additional studies with Dr. Smith and his colleagues, as we further develop my3KG."
NewCardio's innovative 3-D ECG platform technology dramatically improves the accuracy and significantly increases the diagnostic value of the standard 12L ECG. NewCardio is developing the my3KG solution for urgent diagnosis of serious cardiac conditions, including AMI. In clinical studies to date, the my3KG has shown substantially improved diagnostic accuracy relative to the standard 12L ECG, particularly in the most diagnostically challenging patients (such as those with diabetes and electrical conduction abnormalities). Accordingly, the Company believes that its innovative my3KG solution will substantially improve diagnostic timing and accuracy in life-threatening cardiac conditions, and will thereby improve clinical outcomes for a broad range of cardiac patients. The Company plans to file a 510(k) application in late 2011 or early 2012 for FDA approval to market my3KG in the U.S.
About the Society for Academic Emergency Medicine (SAEM)
The SAEM is dedicated to the improvement of care of the acutely ill and injured patient by improving research and education. To achieve this mission, SAEM influences health policy through forums, publications, inter-organizational collaboration, policy development, and consultation services for physicians, teachers, researchers, and students. SAEM represents excellence and leadership in academic emergency medicine and its values include idealism and quality in all endeavors, nurturing and camaraderie and diversity among members, as well as creative and symbiotic interactions with other organizations.
